Artwork

Contenuto fornito da Kunal Sampat and Kunal Sampat | Educator. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Kunal Sampat and Kunal Sampat | Educator o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.
Player FM - App Podcast
Vai offline con l'app Player FM !

Patient Recruitment in Phase I Studies with Dr. Graham Wood

1:06:51
 
Condividi
 

Manage episode 407426913 series 3560084
Contenuto fornito da Kunal Sampat and Kunal Sampat | Educator. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Kunal Sampat and Kunal Sampat | Educator o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

Phase I trials are generally conducted in healthy participants or in patients with no treatment options such as oncology patients.

Unlike late phase trials, Phase I (also known as early phase) studies have different patient recruitment challenges.

To learn more, I invited Dr. Graham Wood, Executive Vice President, USA at Nucleus Network.

Dr. Wood is a leader in the conduct and design of clinical pharmacology studies having held senior executive roles in a number of the top clinical research sites in the world.

In total, he has over 22 years of experience and has been involved with more than 200 first-in-human studies as well as over 2,000 studies across all areas of clinical pharmacology.

After finishing his PhD in Neurology and Neurosurgery, Graham worked at MDS Pharma Services, Cetero Research, Manna Research and Altasciences as well as spending two years working at biotechnology companies.

*

This podcast is brought to you by Slope.

Slope provides an online eClinical Supply Chain Management (eCSCM) platform for sponsors and research sites collaborating on complex, sample-intensive, early-stage clinical trials. The Slope eCSCM platform reduces clinical trial risks, reigns in costs, improves the productivity of clinical trial collaborators, and increases subject retention by moving the manual, spreadsheet-driven, and error-prone processes used to manage and track clinical supplies and biological samples to a digital platform.

To learn more, visit slope.io and ask to speak with a solutions coordinator today.

*

  continue reading

64 episodi

Artwork
iconCondividi
 
Manage episode 407426913 series 3560084
Contenuto fornito da Kunal Sampat and Kunal Sampat | Educator. Tutti i contenuti dei podcast, inclusi episodi, grafica e descrizioni dei podcast, vengono caricati e forniti direttamente da Kunal Sampat and Kunal Sampat | Educator o dal partner della piattaforma podcast. Se ritieni che qualcuno stia utilizzando la tua opera protetta da copyright senza la tua autorizzazione, puoi seguire la procedura descritta qui https://it.player.fm/legal.

Phase I trials are generally conducted in healthy participants or in patients with no treatment options such as oncology patients.

Unlike late phase trials, Phase I (also known as early phase) studies have different patient recruitment challenges.

To learn more, I invited Dr. Graham Wood, Executive Vice President, USA at Nucleus Network.

Dr. Wood is a leader in the conduct and design of clinical pharmacology studies having held senior executive roles in a number of the top clinical research sites in the world.

In total, he has over 22 years of experience and has been involved with more than 200 first-in-human studies as well as over 2,000 studies across all areas of clinical pharmacology.

After finishing his PhD in Neurology and Neurosurgery, Graham worked at MDS Pharma Services, Cetero Research, Manna Research and Altasciences as well as spending two years working at biotechnology companies.

*

This podcast is brought to you by Slope.

Slope provides an online eClinical Supply Chain Management (eCSCM) platform for sponsors and research sites collaborating on complex, sample-intensive, early-stage clinical trials. The Slope eCSCM platform reduces clinical trial risks, reigns in costs, improves the productivity of clinical trial collaborators, and increases subject retention by moving the manual, spreadsheet-driven, and error-prone processes used to manage and track clinical supplies and biological samples to a digital platform.

To learn more, visit slope.io and ask to speak with a solutions coordinator today.

*

  continue reading

64 episodi

Toate episoadele

×
 
Loading …

Benvenuto su Player FM!

Player FM ricerca sul web podcast di alta qualità che tu possa goderti adesso. È la migliore app di podcast e funziona su Android, iPhone e web. Registrati per sincronizzare le iscrizioni su tutti i tuoi dispositivi.

 

Guida rapida